Investment efficiency of new drug R&D enhanced by out-sourcing

Published: 1999-09-21 16:32:00

Updated: 1999-09-21 16:32:00

The commercialization of the first domestic new drug strongly motivated local pharmaceutical industry to seek enhancement of efficiency in new drug R&D investment by means of utilizing the third party resource in their R&D process.

The local drug company should upgrade their R&D investment efficiency not only by their own R&D capability improvement but also by utilizing the outside research ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.